UBC Faculty Research and Publications

Serum omentin-1 level in patients with benign prostatic hyperplasia He, Haiqing; Wu, Shuiqing; Hao, Jun; Wang, Long; Ai, Kai; Zhu, Xuan; Xu, Ran; Zhao, Xiaokun; Wang, Yinhuai; Zhong, Zhaohui

Abstract

Backgroud: To evaluate the relationship between omentin-1 and benign prostatic hyperplasia (BPH). BPH is the most common urological disease in elderly men worldwide. Lower serum omentin-1 levels were reported to be negatively associated with the incidence of inflammation, diabetes, obesity and metabolic syndrome, which all play a role in the development of BPH. To the best of our knowledge, the relationship between omentin-1 and BPH has not been investigated previously. Methods: A total of 70 males participated in this study, including forty patients diagnosed with BPH and thirty healthy males. The anthropometric measurements and the biochemical parameters were measured in this study. We evaluated serum omentin-1 levels and the correlation with those data. We also test the gene expression of IL-8, IL-18 in BPH group using the TURP tissues. Results: The serum omentin-1 levels were lower in the BPH patients than in the control group (27.95 ± 4.18 versus 32.03 ± 5.46, p 

Item Media

Item Citations and Data

License

Attribution 4.0 International (CC BY 4.0)

Usage Statistics